Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Telpegfilgrastim Injection.

This drug is indicated for reducing the incidence of infections manifested by febrile neutropenia in patients with non-myeloid malignancies who are receiving myelosuppressive anticancer drugs that are prone to cause febrile neutropenia.

Share: